Wayfare recognizes the challenges physicians face: limited clinical evidence; confusion over cannabinoid selection, administration, and dosing; and time constraints in your office practice. We are also aware of the lack of educational support in this area, for physicians and patients alike. Our model is similar to those employed in many jurisdictions for diabetes management, which most physicians are familiar with.
Wayfare employs nursing professionals to support you in maintaining medical oversight of patients who opt for cannabis treatment, by:
conducting thorough patient reviews using proven screening tools such as Opioid Risk, CUDIT-R, GAD-7, BPI, PHQ-9, etc.;
considering potential precautions and contraindications;
making recommendations based on the best available evidence and experience;
supporting patients with education and product selection;
monitoring patient progress and suggesting measured adjustments as needed; and
making all records on file and available to you upon request.
Wayfare is not aligned with—or owned by—any single licensed producer.
We have chosen instead to partner with several of the leading producers who have demonstrated a commitment to the medical application of cannabis (by sponsoring research, for example).
This gives patients access to a wider variety of products and ensures uninterrupted supply of appropriate medications.